Spots Global Cancer Trial Database for releasing hormone agonist therapy
Every month we try and update this database with for releasing hormone agonist therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer | NCT00244920 | Prostate Cancer | bicalutamide leuprolide acet... squalamine lact... adjuvant therap... antiandrogen th... antiangiogenesi... conventional su... neoadjuvant the... releasing hormo... | 18 Years - | OHSU Knight Cancer Institute | |
| Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer | NCT00796458 | Pain Prostate Cancer | docetaxel releasing hormo... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | NCT00967954 | Prostate Cancer | antiandrogen th... releasing hormo... DNA analysis RNA analysis comparative gen... gene expression... laboratory biom... diffusion-weigh... magnetic resona... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | NCT00629278 | Breast Cancer | trastuzumab aromatase inhib... cyclophosphamid... docetaxel doxorubicin hyd... epirubicin hydr... fluorouracil paclitaxel releasing hormo... tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Androgen Deprivation Therapy in Treating Patients With Prostate Cancer | NCT00110162 | Prostate Cancer | antiandrogen th... releasing hormo... orchiectomy | - | National Cancer Institute (NCI) | |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | NCT00030654 | Prostate Cancer | bicalutamide docetaxel doxorubicin hyd... estramustine ph... flutamide ketoconazole paclitaxel releasing hormo... vinblastine sul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer | NCT00023829 | Prostate Cancer | bicalutamide flutamide releasing hormo... adjuvant therap... radiation thera... | 0 Years - 120 Years | Radiation Therapy Oncology Group | |
| Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer | NCT00796458 | Pain Prostate Cancer | docetaxel releasing hormo... | 18 Years - | National Cancer Institute (NCI) | |
| Androgen Deprivation Therapy in Treating Patients With Prostate Cancer | NCT00110162 | Prostate Cancer | antiandrogen th... releasing hormo... orchiectomy | - | National Cancer Institute (NCI) | |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | NCT00030654 | Prostate Cancer | bicalutamide docetaxel doxorubicin hyd... estramustine ph... flutamide ketoconazole paclitaxel releasing hormo... vinblastine sul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer | NCT00023829 | Prostate Cancer | bicalutamide flutamide releasing hormo... adjuvant therap... radiation thera... | 0 Years - 120 Years | Radiation Therapy Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
